Read More Pharma Industry News Galderma’s nemolizumab sets new standard in prurigo nodularis treatment with OLYMPIA 1 trial success Galderma’s latest clinical trial has unveiled a significant breakthrough in treating prurigo nodularis, a chronic neuroimmune skin condition… byPallavi MadhirajuNovember 28, 2024